Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 1398 (110th)

Inflammatory Bowel Disease Research Enhancement Act

referredUnited States· United States Congress· EN

Introduced

15 May 2007

Last action

15 May 2007 · Introduced

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6137-6138)

Sponsors

Sen. Reid, Harry [D-NV], Sen. Cochran, Thad [R-MS], Sen. Brown, Sherrod [D-OH], Sen. Sanders, Bernard [I-VT], Sen. Dodd, Christopher J. [D-CT], Sen. Lieberman, Joseph I. [ID-CT], Sen. Stabenow, Debbie [D-MI], Sen. Collins, Susan M. [R-ME], Sen. Johnson, Tim [D-SD], Sen. Lautenberg, Frank R. [D-NJ], Sen. Hatch, Orrin G. [R-UT], Sen. Reed, Jack [D-RI], Sen. Murray, Patty [D-WA], Sen. Feinstein, Dianne [D-CA], Sen. Menendez, Robert [D-NJ]

Subjects

Healthcare, Environment

Source updated

14 August 2025

Healthcare · Environment

Summary

Inflammatory Bowel Disease Research Enhancement Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand, intensify, and coordinate the Institute's research activities on inflammatory bowel disease, with a focus on: (1) genetic research on susceptibility for inflammatory bowel disease; (2) research targeted to increase knowledge about the causes and complications of inflammatory bowel disease in children; (3) animal model research; (4) clinical research; (5) expansion of the Institute's Inflammatory Bowel Disease Centers program with a focus on pediatric research; (6) training of qualified health professionals in biomedical research focused on inflammatory bowel disease; and (7) other research priorities identified in specified scientific agendas. Requires the Director of the Centers for Disease Control and Prevention (CDC) to expand the Inflammatory Bowel Disease Epidemiology Program to include additional studies focused on: (1) the incidence and prevalence of pediatric inflammatory bowel disease in the United States; (2) genetic and environmental factors associated with the disease; (3) age, race or ethnicity, gender, and family history of individuals diagnosed with the disease; and (4) treatment approaches and outcomes.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 15 May 2007

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6137-6138)

    Source: IntroReferral

  2. 15 May 2007

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 15 May 2007

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 15 May 2007

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 15 May 2007

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.